The beneficial actions of bepridil in acute myocardial infarction in anaesthetized dogs
- PMID: 6786404
- PMCID: PMC2071673
- DOI: 10.1111/j.1476-5381.1981.tb10445.x
The beneficial actions of bepridil in acute myocardial infarction in anaesthetized dogs
Abstract
1 When administered intravenously shortly before acute coronary ligation in dogs anaesthetized with chloralose, bepridil (5 mg/kg) produced immediate and transient falls in coronary and systemic vascular resistance which were accompanied by marked decreases in myocardial oxygen extraction. These effects were followed by sustained decreases in heart rate and myocardial oxygen consumption. 2 This dose of bepridil reduced the number of premature ventricular beats and abolished fibrillation induced by coronary artery ligation without modifying the haemodynamic or metabolic consequences (lactate production) of myocardial ischaemia. 3 When administered 1.5-2 h after ligation, bepridil did not compromise the critical perfusion of the acutely ischaemic zone but reduced the lactate production and ST-segment elevation in the ischaemic zone. 4 These results suggest that bepridil may be a useful drug in the chronic treatment of angina pectoris and in this respect may possess advantages over beta-adrenoceptor antagonists.
Similar articles
-
The early consequences of myocardial ischaemia and their modification.J Physiol (Paris). 1980;76(7):699-715. J Physiol (Paris). 1980. PMID: 6783744
-
Dose related coronary and systemic haemodynamic effects of intravenous bepridil in patients with coronary artery disease.Eur Heart J. 1987 Feb;8(2):130-40. doi: 10.1093/oxfordjournals.eurheartj.a062240. Eur Heart J. 1987. PMID: 3494607
-
Antiarrhythmic, haemodynamic and metabolic effects of 3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride in greyhounds following acute coronary artery ligation.Br J Pharmacol. 1975 Nov;55(3):359-68. doi: 10.1111/j.1476-5381.1975.tb06939.x. Br J Pharmacol. 1975. PMID: 1133 Free PMC article.
-
Bepridil: a review of its pharmacology and clinical efficacy as an anti-anginal agent with anti-arrhythmic properties.Pharmatherapeutica. 1985;4(4):195-222. Pharmatherapeutica. 1985. PMID: 2414784 Review.
-
Hemodynamic effects of bepridil in patients with coronary artery disease.Am J Cardiol. 1992 Apr 9;69(11):17D-24D. doi: 10.1016/0002-9149(92)90954-w. Am J Cardiol. 1992. PMID: 1553887 Review.
Cited by
-
Bepridil: a pharmacological reappraisal of its potential beneficial effects in angina and tissue protection following ischemia.Cardiovasc Drugs Ther. 1989 Oct;3(5):731-42. doi: 10.1007/BF01857623. Cardiovasc Drugs Ther. 1989. PMID: 2488109 Review.
-
Effects of Org 7797 on early, late and inducible arrhythmias following coronary artery occlusion in rats and dogs.Br J Pharmacol. 1991 Dec;104(4):853-8. doi: 10.1111/j.1476-5381.1991.tb12517.x. Br J Pharmacol. 1991. PMID: 1810599 Free PMC article.
-
Effects of the calcium entry blocker bepridil on repolarizing and pacemaker currents in sheep cardiac Purkinje fibres.Naunyn Schmiedebergs Arch Pharmacol. 1989 Jun;339(6):638-46. doi: 10.1007/BF00168656. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2475788
-
Lidoflazine in the early stages of acute myocardial ischaemia.Br J Pharmacol. 1982 Jun;76(2):347-54. doi: 10.1111/j.1476-5381.1982.tb09226.x. Br J Pharmacol. 1982. PMID: 7093589 Free PMC article.
-
Bepridil. A review of its pharmacological properties and therapeutic use in stable angina pectoris.Drugs. 1992 Nov;44(5):835-57. doi: 10.2165/00003495-199244050-00009. Drugs. 1992. PMID: 1280569 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical